Compare Amphastar Pharmaceuticals Inc (AMPH) vs Nasdaq100 ETF (QQQ) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

QQQ trades at $723.03, up 1.17% with strong bullish momentum from moving averages and institutional buying interest. The ETF shows technical strength with a bullish overall signal, though RSI_6 at 88.85 indicates potential near-term overbought conditions. Recent news highlights ongoing institutional accumulation and positive momentum in Nasdaq-100 components.

Outlook remains positive given strong technical momentum and institutional support, though elevated short-term RSI suggests potential consolidation. Key risks include expense ratio comparisons with QQQM and tech sector concentration. Analyst consensus is divided with 50% buy and 50% sell ratings.